Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey.
about
Elevated serum procollagen type III peptide in splanchnic and peripheral circulation of patients with inflammatory bowel disease submitted to surgeryIndirect costs of inflammatory bowel diseases: Crohn's disease and ulcerative colitis. A systematic reviewCosts in inflammatory bowel diseasesPhysical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohortsCritical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis.Harnessing person-generated health data to accelerate patient-centered outcomes research: the Crohn's and Colitis Foundation of America PCORnet Patient Powered Research Network (CCFA Partners).Empowering employees with chronic diseases; development of an intervention aimed at job retention and design of a randomised controlled trial.Impact of inflammatory bowel disease on Japanese patients' quality of life: results of a patient questionnaire surveyDisability in Patients with Inflammatory Bowel Disease: Correlations with Quality of Life and Patient's Characteristics.Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study.Hematopoietic cell transplantation for Crohn's disease; is it time?Short pediatric Crohn's disease activity index for quality improvement and observational research.Transitional care in inflammatory bowel disease.Epidemiological characteristics of inflammatory bowel disease in North-Eastern Poland.Role of the enteric microbiota in intestinal homeostasis and inflammationEfficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial.Patient reported symptoms during an ulcerative colitis flare: a Qualitative Focus Group StudyThe Emerging Adult with Inflammatory Bowel Disease: Challenges and Recommendations for the Adult GastroenterologistOut-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory DiseasesGastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidenceEmerging drugs for the treatment of ulcerative colitisDevelopment of an Inflammatory Bowel Disease Research Registry Derived from Observational Electronic Health Record Data for Comprehensive Clinical Phenotyping.Inflammatory bowel disease: a Canadian burden of illness reviewCognitive functioning and depressive symptoms in adolescents with inflammatory bowel disease.Cannabinoids cool the intestine.Do black and Hispanic Americans with inflammatory bowel disease (IBD) receive inferior care compared with white Americans? Uneasy questions and speculations.Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.Quality improvement in inflammatory bowel disease.Bugs, genes, fatty acids, and serotonin: Unraveling inflammatory bowel disease?Drivers of cost after surgical and medical therapy for chronic ulcerative colitis: a nested case-cohort study in Olmsted County, MinnesotaFacilitating empowerment in employees with chronic disease: qualitative analysis of the process of change.Systematic review: The role of race and socioeconomic factors on IBD healthcare delivery and effectiveness.Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications.The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model.Inflammatory bowel disease: Greek patients' perspective on quality of life, information on the disease, work productivity and family supportPsychiatric comorbidity in the treatment of patients with inflammatory bowel disease.Tetomilast: new promise for phosphodiesterase-4 inhibitors?Perspectives and attitudes of young patients with inflammatory bowel disease: symptoms, burden of disease and communication with their healthcare professionals.Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases.
P2860
Q24798856-FD6857B7-E83B-446A-A8BD-E02AA009962AQ26749259-CCA2CEA9-6218-4907-9BB2-89B7AEF95AE8Q26750634-D9695782-2A36-4631-ABFA-B4F2C65F05FAQ28658603-986B8F17-FD6A-45D7-89F2-934B1535A4FAQ30439952-9420B622-EA8B-48EB-9A90-A92D684A5A6DQ30770055-F58CE9E0-BC24-4821-9029-33267009D31CQ33382516-E6D9F169-C51A-4FFF-9630-9FD5DCB598CBQ33580981-CD245497-B5AB-4F3C-9845-4B4C1581E443Q33786688-83BBEF95-07EC-4404-B818-1EE9C907C422Q33981316-CD97A96A-2AAD-4A3C-82E1-5CA88A287A44Q34017756-4200DEE3-BA31-4BB1-A238-6B8B110CA343Q34388238-75D8B52A-17CE-4895-9722-98CFB8A14AAFQ34571165-44DE7827-0BF8-4D28-8A9E-84F6BF204CBEQ35010645-E9DD9DDE-33E9-4FB2-86AE-20C3F75C5C5EQ35052712-60795E3F-D399-4D6F-857F-E3C3857AE62AQ35268107-F049B9D7-F095-4E91-8EFB-96CC9090BEFEQ35344679-0ABE7B70-C9B7-4C2D-8785-4114BA7EFD41Q35614324-C9DE7EF0-CC86-423B-9DB4-C1AF09442E57Q35624933-6710FD3E-2A5B-4908-BCED-123C59FF9FA8Q35738486-58AF22F2-614B-4A01-8622-6C4B9DE25FB9Q35768888-58DC23C2-12EC-402B-A181-78A3E6C8802AQ36039436-D5A6B5FC-E691-4567-8D97-4C7B10CE9529Q36130473-5541B866-368D-4F53-B256-31E370E826C8Q36391797-FD6D3B80-5D89-4C1F-8E31-CE77C1239DC0Q36699209-96A0419F-F0B9-4556-A3B9-DF04653E1570Q36837926-A9D9F036-4B52-4E38-A6BC-5260D3F3E551Q36860982-107B9093-B1EB-4D3F-A592-FFDC148CE741Q37035957-3DD28CFD-43AE-47E9-8C42-E3DA4EFB026FQ37088512-769DE10E-39BE-40A8-BC16-27F72F279A18Q37130920-1DDC5641-030D-4621-982A-5A36F502D3DEQ37131424-E7E42F69-6852-451A-A613-FE85D631FB29Q37416160-6189BC59-681D-4B8C-ABD7-EBC81DD0173AQ37528116-EDE78B6B-449F-44AD-8839-EC51AAE9F4A9Q37597661-4BBA8218-0076-4885-BEEB-7BAD95523E4CQ37599087-9455A519-DA37-4351-9C9E-76B0396E6927Q37647663-DD04DA02-CD1D-4099-8F0B-12E4777D8BA7Q37682510-686ECDD1-FE1B-4D70-863E-AD5564E659B6Q38050167-5EBE850E-AF73-4B81-BCCA-10EFE2A0BD81Q38609020-FA5E3A3C-AB92-4E91-9DC2-04437E1927F7Q38630959-6D78E1A4-EAA6-47E0-9123-41844377F43B
P2860
Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Work losses related to inflamm ...... ional Health Interview Survey.
@en
Work losses related to inflamm ...... ional Health Interview Survey.
@nl
type
label
Work losses related to inflamm ...... ional Health Interview Survey.
@en
Work losses related to inflamm ...... ional Health Interview Survey.
@nl
prefLabel
Work losses related to inflamm ...... ional Health Interview Survey.
@en
Work losses related to inflamm ...... ional Health Interview Survey.
@nl
P2093
P2860
P1476
Work losses related to inflamm ...... ional Health Interview Survey.
@en
P2093
Charles N Bernstein
Philip Jacobs
Teresa Longobardi
P2860
P304
P356
10.1111/J.1572-0241.2003.07285.X
P407
P577
2003-05-01T00:00:00Z